<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Internal Medicine: Nail Diseases Topic Collection</title>
    <link>http://archinte.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Sat, 01 Dec 2012 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 01 Jan 2013 00:49:13 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archinte.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archinte.jamanetwork.com</webMaster>
    <item>
      <title>Office Practice–Based Confirmation of Onychomycosis A US Nationwide Prospective Survey </title>
      <link>http://archinte.jamanetwork.com/article.aspx?articleID=213437</link>
      <pubDate>Mon, 14 Oct 2002 00:00:00 GMT</pubDate>
      <author>Elewski BE, Leyden J, Rinaldi MG, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Background&lt;/div&gt;Onychomycosis is sufficiently prevalent to be seen and treated by primary care physicians. The diagnosis of onychomycosis is most often confirmed from nail specimens by microscopy and fungal culture done at a central laboratory; these are relatively expensive tests with a turnaround time of a month or more. This study was conducted (1) to evaluate the use of in-office dermatophyte test medium (DTM) culture, and (2) to determine the epidemiology of onychomycosis in a large, nationwide sample of patients who were not participants in a clinical trial.&lt;div class="boxTitle"&gt;Methods&lt;/div&gt;A nationwide sample of primary care physicians and podiatrists enrolled 670 patients with clinical signs of toenail onychomycosis. Dermatophyte test medium cultures were performed in the office and the results were compared with fungal cultures performed by a central laboratory.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;Central laboratory fungal cultures were positive in 44% (n = 297) of patients and DTM cultures in 51% (n = 345). Dermatophytes accounted for 93% of the confirmed infections and nondermatophyte molds the rest. In the 617 patients with paired dermatophyte test medium and laboratory fungal culture results, the 2 tests were in agreement (both positive or both negative) in 68% of cases (κ, 0.37; asymptotic SE, 0.04; 95% confidence interval, 0.299-0.441).&lt;div class="boxTitle"&gt;Conclusions&lt;/div&gt;A DTM culture is a relatively rapid, easy, and inexpensive method to confirm dermatophyte infections in patients with signs of onychomycosis in the primary care setting. Because the available drugs for treating onychomycosis are effective against all dermatophyte species, the confirmation of dermatophyte infection, without further identification of genus and species, is sufficient evidence to begin treatment.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">162</prism:volume>
      <prism:number xmlns:prism="prism">18</prism:number>
      <prism:startingPage xmlns:prism="prism">2133</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">2138</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/archinte.162.18.2133</prism:doi>
      <guid>http://archinte.jamanetwork.com/article.aspx?articleID=213437</guid>
    </item>
  </channel>
</rss>